---
category: news
title: "Castle Biosciences Launches DecisionDx-Melanoma Integrated Test Result Utilizing Artificial Intelligence to Predict Individualized Risk"
excerpt: "Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that DecisionDxÂ®-Melanoma,"
publishedDateTime: 2021-03-08T21:05:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-science-north-america-biology-skin-disorders-c2c0a62a21dc45dbae401a109f6b4afd"
webUrl: "https://apnews.com/press-release/business-wire/technology-science-north-america-biology-skin-disorders-c2c0a62a21dc45dbae401a109f6b4afd"
type: article
quality: 7
heat: 7
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - Machine Learning
  - AI
  - AI in Healthcare

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "X/9NViaq/rmlac4nHi/OfmB0Js70ksckILW+StNbUexOXfwdbZxDUpTezFEF/agHg+TUX/iQJHbV6eMs5khrBif4uP6itfsaoUxmFeQanBHAxAxQl/5aJsx6CGl8yjhET3f4HBUxgP1/Kct4/U/gCLMta+TX8oGzz4C6XPyzUQUId+6E+fTO7AiRI71ARL2Q7ZgKanlXaictlcLx3yANycIVfnj9jhtCyUauOzr790Q+PbWfxMbGcZsEf0Iw3/fr7xed9+xwjyYzMR2mupN7m6y/qCq1i8P3kqIi/EpwplXMeLr4JMHcRUoHUVk8/2LMVrNGc38t801lZg/0vXZFQ22aw1cYNdauH25f/cNrSAc=;SMAQEjr9eaL92Jfef62UIw=="
---

